Article Details

FBR & Co Issues “Outperform” Rating for Rexahn Pharmaceuticals, Inc. (RNN)

Retrieved on: 2018-07-07 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

FBR & Co Issues “Outperform” Rating for Rexahn Pharmaceuticals, Inc. (RNN). View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. increased its stake in shares of Rexahn Pharmaceuticals, Inc. (NYSE:RNN) by 1.0% during the second quarter, according to its ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up